The ZEPTOLink IOL Positioning System, which integrates the ZEPTO precision pulse capsulotomy technology with any phaco system, is designed to increase the efficiency and precision of cataract surgery
A product image of ZEPTOLink Console. (Credit: PRNewsfoto/Centricity Vision)
Ophthalmic technology company Centricity Vision announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance for its new ZEPTOLink intraocular lens (IOL) Positioning System.
The ZEPTOLink IOL Positioning System is designed to increase the efficiency and precision of cataract surgery by integrating the ZEPTO precision pulse capsulotomy technology with any phacoemulsification (phaco) system.
ZEPTO is said to produce an instantaneous capsulotomy along with consistent, 360-degree IOL overlap by applying 12 micro-pulses of energy in four milliseconds. This optimises the lens positioning on the patient’s visual axis and improves the outcomes.
According to the US-based Centricity Vision, the integration of the ZEPTOLink platform with any phaco system saves time and space in the operating room.
ZEPTOLink provides surgeons with full control through the phaco foot pedal along with the same strong, consistent, centred capsulotomy, said the ophthalmic technology company.
The positioning system leverages suction and irrigation provided by the phaco system. This enables doctors to completely control the ZEPTO handpiece apposition, energy delivery, suction, and release using the phaco foot pedal.
Additionally, ZEPTOLink is said to have a small ergonomic console that attaches to any phaco system and an advanced touchscreen display with voice-supported functions.
It also has a dedicated ZEPTOLink handpiece for efficient set-up, priming, and operation by a single individual all within the sterile field.
Centricity Vision president and CEO Rob Thornhill said: “By improving IOL centration and operating room productivity, ZEPTOLink will benefit patients and practices alike.
“We believe this streamlined surgical solution will help drive the future of automated refractive cataract surgery.”
The company is planning to introduce ZEPTOLink at the American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting in San Diego.
In the future, Centricity Vision has plans for a phase-wise launch of the positioning system in the US, with a broader commercial rollout later this year.